Fluidigm will acquire DVS Sciences in an approximately $207.5 million cash and stock deal that expands the buyer’s portfolio of technologies serving the single-cell genomics and proteomics markets, ...
Fluidigm ($FLDM) and DVS Sciences announced Wednesday they're merging in a tie-up for which Fluidigm will pay $207.5 million in stock and cash to buy out its San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results